New drug combo shows promise for tough prostate cancer
Disease control
Completed
This study tested a new drug called vudalimab, alone or with standard treatments, in 72 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to see if the drug is safe and can shrink tumors or lower PSA levels. Participants had to have cancer…
Phase: PHASE2 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC